Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.

ABSTRACT:

SUBMITTER: Silk SE 

PROVIDER: S-EPMC12184842 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature